The Smart Investor
    Facebook Instagram
    Wednesday, August 10
    Facebook Instagram LinkedIn
    The Smart Investor
    • Home
    • About
      • About Us
      • Careers
    • Smart Investing
      • Getting Started
      • Investing Strategy
      • Smart Analysis
      • Smart Reads
    • Special Free Reports!
    • As Featured on BT
    • Our Services
      • Our Services
      • Subscribe now!
    • Login
    • Cart
    The Smart Investor
    Home»Growth Stocks»Here’s Why Genomics Looks Set to Permanently Change the Face of Medicine
    Growth Stocks

    Here’s Why Genomics Looks Set to Permanently Change the Face of Medicine

    The idea of personalised medicine and early disease detection may not be as far-fetched as it sounds.
    Royston YangBy Royston YangNovember 25, 20211 Min Read
    Facebook Twitter LinkedIn Email WhatsApp
    Genomics
    Share
    Facebook Twitter LinkedIn Email WhatsApp

    It’s April 2003, and a project that took 13 years and US$2.7 billion to complete is about to change the study of medicine and the human body forever.

    I am talking about the Human Genome Project, which has successfully sequenced the 20,000 genes that make up the blueprint of our bodies.

    That’s almost three billion base pairs of deoxyribonucleic acid, or DNA, that make up not just our anatomy but give us all our individual, unique characteristics.

    Genomics, or the study of genes, was only made possible once this incredible milestone had been achieved.

    Please click HERE to read the rest of this article.

    Share. Facebook Twitter LinkedIn Email WhatsApp

    Related Posts

    5 Singapore REITs That Upped Their DPU in August

    August 10, 2022

    3 Singapore Blue-Chip Stocks Raising Their Dividends Before National Day

    August 9, 2022

    Sembcorp Industries Doubles its Interim Dividend: 5 Highlights from its 1H2022 Earnings

    August 9, 2022
    Facebook Instagram LinkedIn Telegram
    • Careers
    • Disclaimer & Privacy Policy
    • Subscription Terms of Service
    © 2022 The Smart Investor. All Rights Reserved. The Smart Investor, thesmartinvestor.com.sg, an investment education website managed by The Investing Hustle Pte Ltd (Company Reg No. 201933459Z) is not licensed or otherwise regulated by the Monetary Authority of Singapore, and in particular, is not licensed or regulated to carry on business in providing any financial advisory service. Accordingly, any information provided on this site is meant purely for informational and investor educational purposes and should not be relied upon as financial advice. No information is presented with the intention to induce any reader to buy, sell, or hold a particular investment product or class of investment products. Rather, the information is presented for the purpose and intentions of educating readers on matters relating to financial literacy and investor education. Accordingly, any statement of opinion on this site is wholly generic and not tailored to take into account the personal needs and unique circumstances of any reader. The Smart Investor does not recommend any particular course of action in relation to any investment product or class of investment products. Readers are encouraged to exercise their own judgment and have regard to their own personal needs and circumstances before making any investment decision, and not rely on any statement of opinion that may be found on this site.

    Type above and press Enter to search. Press Esc to cancel.